Investments in and Advances to Unconsolidated Companies	6 Months Ended
Jun. 26, 2026
Investments in and Advances to Affiliates [Abstract]
Investments in and Advances to Unconsolidated Companies	Investments in and Advances to Unconsolidated Companies Investments in and advances to unconsolidated companies amounted to $49.0 million as of June 26, 2026 and $63.2 million as of December 26, 2025. These investments are accounted for under the equity method of accounting, and primarily relate to investments in limited partnerships and joint ventures in the food, nutrition, and agricultural technology sectors. Our investments in unconsolidated companies include investments in companies who qualify as investment companies pursuant to Accounting Standards Codification Topic 946, Financial Services - Investment Companies ("ASC 946") and, accordingly, are carried at net asset value ("NAV"), which approximates fair value. Our investments in unconsolidated companies which qualify as investment companies under ASC 946, which make up approximately $38.3 million of the balance as of June 26, 2026 and $52.9 million of the balance as of December 26, 2025, cannot be redeemed, but the funds will make distributions through liquidation. The estimate of the liquidation period varies from 2027 to 2038. Total unfunded commitments related to our investments in and advances to unconsolidated companies as of June 26, 2026 were $10.6 million. Our proportionate share of income related to these unconsolidated companies was $1.9 million and $7.8 million for the quarters ended June 26, 2026 and June 27, 2025, respectively and $8.5 million and $7.8 million from the six months ended June 26, 2026 and June 27, 2025, respectively. These amounts are included in "Other expense, net" in the Consolidated Statements of Operations. No distributions were received from these investments for the quarter ended June 26, 2026. Distributions received from these investments were $0.3 million for the quarter ended June 27, 2025, and $29.6 million and $1.1 million for six months ended June 26, 2026 and June 27, 2025, respectively. The $29.6 million distribution received for six months ended June 26, 2026 was as a result of the January 2026 liquidation of an investment fund whose carrying value made up $23.0 million of our investments in and advances to unconsolidated companies as of December 26, 2025.

Investments in and advances to unconsolidated companies amounted to $49.0 million as of June 26, 2026 and $63.2 million as of December 26, 2025. These investments are accounted for under the equity method of accounting, and primarily relate to investments in limited partnerships and joint ventures in the food, nutrition, and agricultural technology sectors. Our investments in unconsolidated companies include investments in companies who qualify as investment companies pursuant to Accounting Standards Codification Topic 946, Financial Services - Investment Companies ("ASC 946") and, accordingly, are carried at net asset value ("NAV"), which approximates fair value. Our investments in unconsolidated companies which qualify as investment companies under ASC 946, which make up approximately $38.3 million of the balance as of June 26, 2026 and $52.9 million of the balance as of December 26, 2025, cannot be redeemed, but the funds will make distributions through liquidation. The estimate of the liquidation period varies from 2027 to 2038. Total unfunded commitments related to our investments in and advances to unconsolidated companies as of June 26, 2026 were $10.6 million.

Our proportionate share of income related to these unconsolidated companies was $1.9 million and $7.8 million for the quarters ended June 26, 2026 and June 27, 2025, respectively and $8.5 million and $7.8 million from the six months ended June 26, 2026 and June 27, 2025, respectively. These amounts are included in "Other expense, net" in the Consolidated Statements of Operations. No distributions were received from these investments for the quarter ended June 26, 2026. Distributions received from these investments were $0.3 million for the quarter ended June 27, 2025, and $29.6 million and $1.1 million for six months ended June 26, 2026 and June 27, 2025, respectively. The $29.6 million distribution received for six months ended June 26, 2026 was as a result of the January 2026 liquidation of an investment fund whose carrying value made up $23.0 million of our investments in and advances to unconsolidated companies as of December 26, 2025.